Lancet Oncol. 2018 Sep;19(9):1239-1246. doi: 10.1016/S1470-2045(18)30349-8. Epub 2018 Aug 3.Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractoryovarian cancer (AEROC): a phase 2, single-arm, prospective study.Lan CY1, Wang Y1, Xiong Y1, Li JD1, Shen JX2, Li YF1, Zheng M1, Zhang YN1, Feng YL1, Liu Q3, Huang HQ4, Huang X5.